273 results match your criteria: "a AbbVie Bioresearch Center; Global Biologics ; Worcester[Affiliation]"

Alterations to post-translational crosslinking modifications in the extracellular matrix (ECM) are known to drive the pathogenesis of fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Thus, the methodology for measuring crosslinking dynamics is valuable for understanding disease progression. The existing crosslinking analysis sample preparation and liquid chromatography tandem mass spectrometry (LC-MS/MS) methods are typically labor-intensive and time-consuming which limits throughput.

View Article and Find Full Text PDF

Pathology, a fundamental discipline that bridges basic scientific discovery to the clinic, is integral to successful drug development. Intrinsically multimodal and multidimensional, anatomic pathology continues to be empowered by advancements in molecular and digital technologies enabling the spatial tissue detection of biomolecules such as genes, transcripts, and proteins. Over the past two decades, breakthroughs in spatial molecular biology technologies and advancements in automation and digitization of laboratory processes have enabled the implementation of higher throughput assays and the generation of extensive molecular data sets from tissue sections in biopharmaceutical research and development research units.

View Article and Find Full Text PDF

Enhancing aggregate reduction using anion exchange hybrid filter in an immunocytokine diabody fusion protein purification process.

J Chromatogr A

January 2025

Analytical Development, BDL, PDS&T, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA; Previously Purification Development, BDL, PDS&T, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA.

Significant aggregation challenges were encountered during the manufacturing processing of an immunocytokine diabody fusion protein. To mitigate this issue and reduce aggregates in the purification process, a variety of depth filters were evaluated for harvest clarification and post-Protein A intermediate filtration. Emphaze™ AEX Hybrid Purifier, a fully synthetic quaternary amine functionalized anion exchange (AEX) nonwoven filter, was found to be particularly effective in removing aggregates during both harvest clarification and post-Protein A intermediate filtration steps.

View Article and Find Full Text PDF

Adeno-Associated Virus (AAV) is often selected as the vector of choice for gene therapy due to its superior clinical performance compared to other gene delivery systems. Currently the characterization of AAV degradation, especially the chemical degradation of capsid, has been limited due to lack of suitable methods. Our study using AAV9 as a model molecule shows that anion exchange chromatography (AEX) as a charge-based separation method has limitations in monitoring the chemical degradation of AAV9 capsid due to a confounding effect from DNA cargo ejection.

View Article and Find Full Text PDF

Introduction: The Modified Multiplier of the SES-CD (MM-SES-CD) refines the assessment of endoscopic Crohn's Disease (CD) severity by differentially weighting parameters in the original SES-CD. A threshold of <22.5 for MM-SES-CD suggests endoscopic remission and correlates with a low risk of long-term disease progression.

View Article and Find Full Text PDF

Repulsive guidance molecule A (RGMa) is upregulated in neurodegenerative diseases. To assess RGMa levels in human serum and cerebrospinal fluid (CSF), a quantification method was developed and validated according to ICH M10 guideline. Sample preparation consisted of immunoprecipitation (IP, only for serum), digestion and purification followed by MS.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of a JAK1-selective inhibitor (ABT-317) on systemic lupus erythematosus (SLE) in mice, exploring both preventive and therapeutic benefits.
  • Treatment with ABT-317 shows promising results, as it improves kidney and saliva functions, reduces inflammation, and leads to significant health improvements in treated mice.
  • The findings suggest that JAK1 inhibition could translate into effective treatments for human lupus nephritis, with potential long-lasting effects even after stopping the drug.
View Article and Find Full Text PDF
Article Synopsis
  • This study explores the similarities between Crohn's disease (CD) and ulcerative colitis (UC) by identifying shared molecular subtypes in patients, suggesting they may have common underlying mechanisms.
  • Researchers integrated data from several datasets to classify patients into two molecular subtypes, one related to immune responses and the other focused on metabolic functions, each with distinct gene modules and cell types.
  • The findings indicate that these subtypes can predict treatment responses, with one subtype showing higher effectiveness for certain therapies, helping to personalize treatment approaches for IBD patients.
View Article and Find Full Text PDF
Article Synopsis
  • Upadacitinib, an oral Janus kinase inhibitor, showed effectiveness in treating moderate-to-severe Crohn's disease through phase 3 trials, specifically focusing on patients with fistulizing disease.
  • * In these studies, patients with fistulas were treated with either upadacitinib or a placebo, and outcomes included resolution of drainage and closure of external openings.
  • * Results indicated that upadacitinib significantly improved rates of drainage resolution and closure of perianal fistulas compared to placebo, showing promising clinical benefits for this patient group.
View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) is a leading cause of dementia that is fatal, and most treatments targeting amyloid beta have only limited success in slowing progression.
  • Research into senescent cells (SC) and their harmful effects shows potential for new therapies, as treating aged monkeys with the senolytic drug navitoclax led to positive changes in biomarkers related to neuroinflammation and neuronal damage.
  • Navitoclax was found to be safe and well tolerated in the study, suggesting its promise as a new therapeutic approach for addressing AD in humans.
View Article and Find Full Text PDF

Structure of anellovirus-like particles reveal a mechanism for immune evasion.

Nat Commun

August 2024

Ring Therapeutics, 140 First Street Suite 300, Cambridge, MA, 02139, USA.

Article Synopsis
  • * Researchers used cryogenic electron microscopy to reveal the structure of an ANV-like particle, which is made up of 60 capsid proteins forming an icosahedral shape with crown-like spikes.
  • * The spike structure may help ANVs evade the immune system by concealing essential parts while showcasing diverse regions to confuse antibodies, offering insights into their immune interactions.
View Article and Find Full Text PDF

Importance: Black or African American (hereinafter, Black) and Hispanic or Latino/a/x (hereinafter, Latinx) adults are disproportionally affected by Alzheimer disease, but most research studies do not enroll adequate numbers of both of these populations. The Alzheimer's Disease Neuroimaging Initiative-3 (ADNI3) launched a diversity taskforce to pilot a multipronged effort to increase the study inclusion of Black and Latinx older adults.

Objective: To describe and evaluate the culturally informed and community-engaged inclusion efforts to increase the screening and enrollment of Black and Latinx older adults in ADNI3.

View Article and Find Full Text PDF
Article Synopsis
  • Early evaluation of antibody off-target binding is crucial to reduce risks like quick clearance and toxicity, with the baculovirus particle (BVP) binding assay commonly used for this purpose.
  • This study introduces a new set of three deep learning models that utilize protein language models to predict outcomes in BVP assays and a complementary bovine serum albumin binding assay.
  • The models effectively predicted assay results for various antibody types, marking a significant advancement in computational methods for antibody development.
View Article and Find Full Text PDF
Article Synopsis
  • - A virtual library of substituted benzoic acid analogues was created to explore the atropisomers of GSK866, a non-steroidal glucocorticoid receptor modulator, using torsion angle scans to find stable compounds.
  • - After synthesizing the compounds, analysis confirmed that two compounds (13 and 14) existed as stable atropisomer pairs (13a, 13b, 14a, and 14b), matching earlier predictions.
  • - Screening in a glucocorticoid receptor assay revealed that one compound from each atropisomer pair was significantly more effective, while docking studies helped determine the stereochemistry of the most potent compounds 13a and 14b.
View Article and Find Full Text PDF

Computing free energy differences between metastable states characterized by nonoverlapping Boltzmann distributions is often a computationally intensive endeavor, usually requiring chains of intermediate states to connect them. Targeted free energy perturbation (TFEP) can significantly lower the computational cost of FEP calculations by choosing a set of invertible maps used to directly connect the distributions of interest, achieving the necessary statistically significant overlaps without sampling any intermediate states. Probabilistic generative models (PGMs) based on normalizing flow architectures can make it much easier via machine learning to train invertible maps needed for TFEP.

View Article and Find Full Text PDF

Idiopathic pulmonary fibrosis (IPF) is an age-related disease with poor prognosis and limited therapeutic options. Activation of lung fibroblasts and differentiation to myofibroblasts are the principal effectors of disease pathology, but damage and senescence of alveolar epithelial cells, specifically type II (ATII) cells, has recently been identified as a potential trigger event for the progressive disease cycle. Targeting ATII senescence and the senescence-associated secretory phenotype (SASP) is an attractive therapeutic strategy; however, translatable primary human cell models that enable mechanistic studies and drug development are lacking.

View Article and Find Full Text PDF

Objectives: The aim of these studies was to characterise the molecular effects of a tool JAK1 inhibitor on cultured primary fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA) through both total and individual cell analysis.

Methods: RA-FLS cultures from 6 (Bulk RNA-seq) or 4 (ScRNA-seq) donors were pre-treated with various concentrations (100 nM and 1μM) of ABT-317 with/without exposure to 25% SEB-conditioned PBMC medium to mimic the RA inflammatory milieu. Cells were subjected to both bulk RNA-seq (36 libraries) and single cell RNA-seq (scRNA-seq; 24 libraries) to identify biological processes impacted by CM and ABT-317 treatments.

View Article and Find Full Text PDF

Insight Into the Degradation Pathways of an AAV9.

J Pharm Sci

September 2024

Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States. Electronic address:

The use of recombinant adeno-associated virus (AAV) vectors is a popular choice for in vivo gene therapy, with hundreds of ongoing clinical trials targeting various genetic diseases. However, due to limited material availability and the complexity of AAV structure, there is a critical lack of comprehensive studies on AAV degradation pathways. In this study, we intended to elucidate the degradation pathways for a model AAV9 with GFP as the transgene under relevant stressed conditions.

View Article and Find Full Text PDF
Article Synopsis
  • Crohn's disease (CD) is a type of inflammatory bowel disease marked by damage throughout the intestinal wall, and achieving "transmural healing" (TH) is seen as important for effective treatment and remission.
  • Current research on Crohn's has largely focused on the intestinal lining, neglecting the role of the deeper intestinal wall.
  • By using advanced techniques to analyze immune and cell profiles in both the mucosal and deeper layers, researchers found differences in gene expression and protein profiles that could help identify new therapies for chronic refractory CD aimed at achieving TH.
View Article and Find Full Text PDF

DC inhibitory receptor (DCIR) is a C-type lectin receptor selectively expressed on myeloid cells, including monocytes, macrophages, DCs, and neutrophils. Its role in immune regulation has been implicated in murine models and human genome-wide association studies, suggesting defective DCIR function associates with increased susceptibility to autoimmune diseases such as rheumatoid arthritis, lupus, and Sjögren's syndrome. However, little is known about the mechanisms underlying DCIR activation to dampen inflammation.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers discovered a new glucocorticoid receptor modulator (GRM) that uses a thioester payload, designed to be quickly processed by the liver to reduce overall exposure in the body.
  • This new payload clears from the system 10 times faster than earlier versions, leading to much lower drug levels and less risk of systemic effects.
  • The antibody-drug conjugate demonstrated significant effectiveness in reducing inflammation in various mouse models, indicating potential for effective subcutaneous administration and applications in treating inflammatory diseases.
View Article and Find Full Text PDF

Aggregation of misfolded α-synuclein (α-syn) is a key characteristic feature of Parkinson's disease (PD) and related synucleinopathies. The nature of these aggregates and their contribution to cellular dysfunction is still not clearly elucidated. We employed mass spectrometry-based total and phospho-proteomics to characterize the underlying molecular and biological changes due to α-syn aggregation using the M83 mouse primary neuronal model of PD.

View Article and Find Full Text PDF